Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Cancer
|
July 9, 1998
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin
R Heller, M J Jaroszeski, D S Reintgen, et al.
Cancer
|
March 1, 1972
Combination sequential chemotherapy in advanced reticulum cell sarcoma
M Levitt, J C Marsh, R C DeConti, et al.
Connecticut Medicine
|
December 1, 1970
The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report
M Levitt, R C DeConti, H A Pearson, et al.
Cancer Research
|
July 1, 1972
Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone
R C DeConti, B R Toftness, K C Agrawal, et al.
American Journal of Clinical Oncology
|
April 1, 1996
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer
S C Remick, M Chmura, C Bromberg, et al.
Cancer Chemotherapy and Pharmacology
|
May 29, 2010
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma
A I Daud, C Xu, W-J Hwu, et al.
British Journal of Cancer
|
October 7, 2010
Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma
R C DeConti, A P Algazi, S Andrews, et al.
Cancer Treatment Reports
|
April 1, 1986
Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study
K M Rowland, S G Taylor, A S Spiers, et al.
Cancer
|
January 1, 1991
A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer
D H Johnson, J C Ruckdeschel, J H Keller, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
March 31, 2000
Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma)
D F Smith, J L Messina, R Perrott, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Cancer
|
July 9, 1998
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin
R Heller, M J Jaroszeski, D S Reintgen, et al.
Cancer
|
March 1, 1972
Combination sequential chemotherapy in advanced reticulum cell sarcoma
M Levitt, J C Marsh, R C DeConti, et al.
Connecticut Medicine
|
December 1, 1970
The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report
M Levitt, R C DeConti, H A Pearson, et al.
Cancer Research
|
July 1, 1972
Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone
R C DeConti, B R Toftness, K C Agrawal, et al.
American Journal of Clinical Oncology
|
April 1, 1996
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer
S C Remick, M Chmura, C Bromberg, et al.
Cancer Chemotherapy and Pharmacology
|
May 29, 2010
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma
A I Daud, C Xu, W-J Hwu, et al.
British Journal of Cancer
|
October 7, 2010
Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma
R C DeConti, A P Algazi, S Andrews, et al.
Cancer Treatment Reports
|
April 1, 1986
Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study
K M Rowland, S G Taylor, A S Spiers, et al.
Cancer
|
January 1, 1991
A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer
D H Johnson, J C Ruckdeschel, J H Keller, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
March 31, 2000
Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma)
D F Smith, J L Messina, R Perrott, et al.
Page
of 5